At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
CGM Informeddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Professional Continuous Glucose Monitoring Before Starting Insulin Pump Therapy
In Brief
A clinical study evaluating CGM Informed for Type 1 Diabetes Mellitus. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The purpose of the study is to learn more about blood glucose control when people with Type 1 Diabetes switch to an insulin pump. The investigators hope to learn whether using a continuous glucose monitor (CGM) helps to create personalized insulin doses that may lead to stable blood glucoses and less frequent insulin pump dose changes during the transition to an insulin pump.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedJun 2016
Primary CompletionMay 2017
TodayJul 2026
First PostedJun 27, 2016
Enrollment StartMar 1, 2016
Primary CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.0 years ago
Interventions
CGM Informeddevice